LeMaitre Q1 2026 sales $66.6M (+11%), EPS $0.68 (+42%); raises FY guidance

LEMAITRE VASCULAR INC

2026-Q1 EPS reported $0.68 revenue$66,551,000

Q1 sales $66.6M (up 11% YoY, 10% organic); gross margin 72.7% (+350 bps); EPS $0.68 (+42%).
Operating income $17.8M (+41%), op margin 27%; cash grew to $367.2M.
Artegraft grew 36% worldwide; records for grafts (+20%), valvulotomes (+15%), carotid shunts (+11%).
Quarterly dividend $0.25/share (payable June 4, record May 21); $100M share repurchase program active.
FY 2026 guidance: sales $277-283M (mid $280M, +12%), EPS $2.93-3.08 (mid $3.00, +26% adj.).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

LEMAITRE VASCULAR INC reported Q2 2026 results: revenue $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.), EPS $0.79 - $0.84 (Mid $0.81, +35%.). Guidance raised.

Period: Q2 2026
Revenue: $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.)
EPS: $0.79 - $0.84 (Mid $0.81, +35%.)
Guidance: raised
Result: guidance update

Exact text from the filing

Business Outlook Q2 2026 Guidance Full Year Guidance Sales $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.) $277mm - $283mm (Mid $280mm, +12%, +12% org.) Gross Margin 72.1% 72.3% Op. Income $20.8mm - $22.3mm (Mid $21.6mm, +34%) $77.6mm - $82.0mm (Mid $79.8mm, +18%, +24% adj.) Op. Margin (Mid) 30% 29% EPS $0.79 - $0.84 (Mid $0.81, +35%.) $2.93 - $3.08 (Mid $3.00, +19%, +26% adj.)

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

LEMAITRE VASCULAR INC reported Q1 2026 results: revenue Sales $66.6mm, EPS EPS $0.68.

Period: Q1 2026
Revenue: Sales $66.6mm
EPS: EPS $0.68
Result: reported results

Exact text from the filing

LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance. Q1 2026: • Sales $66.6mm, +11% (+10% organic) vs. Q1 2025 • Gross margin 72.7% (+350 bps) • Op. income $17.8mm (+41%) • Op. margin 27% • EPS $0.68 (+42%) • Cash up $8.1mm sequentially to $367.2mm

View on SEC.gov

3 earnings releases filed in the last 30 days. Browse all earnings releases →

LEMAITRE VASCULAR INC filing history →

Source: SEC EDGAR

accession 0001193125-26-206578

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.